The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism
NCT02362256 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2015-02-12
Summary
The aim of this study is to investigate which method of naltrexone induction during rapid opioid detoxification causes stronger stress response and has a higher influence on opioid abstinence caused by opioid induction.
Conditions
- Opiate Addiction
Interventions
- DRUG
-
Naltrexone
- DRUG
-
Clonidine
- DRUG
-
Lorazepam
Sponsors & Collaborators
-
Vilnius University
lead OTHER
Principal Investigators
-
ROBERTAS BADARAS, MD · Vilnius University Clinic of Anaesthesiology and Intensive Care
-
JUOZAS IVASKEVICIUS, PROFESSOR · Vilnius University Clinic of Anaesthesiology and Intensive Care
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-09-30
Countries
- Lithuania
Study Locations
More Related Trials
-
Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1
NCT00032955 ·Status: COMPLETED ·Phase: PHASE3
-
Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder
NCT03169816 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
NCT05011266 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Buprenorphine Pharmacology Related to Addiction Treatment - 18
NCT00000236 ·Status: COMPLETED ·Phase: PHASE2
-
Dronabinol Naltrexone Treatment for Opioid Dependence
NCT01024335 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Improved Strategies for Outpatient Opioid Detoxification
NCT01377610 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site
NCT00781898 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
NCT00000299 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Safety of Acute Baclofen in Methadone-maintained Individuals With Opiate Dependence.
NCT05161351 ·Status: COMPLETED ·Phase: PHASE4
-
Examining the Role of the Orexin System in Sleep and Stress in Persons With Opioid Use Disorder
NCT04287062 ·Status: COMPLETED ·Phase: PHASE2
-
Long-acting Naltrexone for Pre-release Prisoners
NCT02867124 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine Naltrexone-P1 A-Cocaine
NCT00733720 ·Status: COMPLETED ·Phase: PHASE1
-
Naltrexone Implants as Relapse Prevention
NCT00269607 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts
NCT00142948 ·Status: COMPLETED ·Phase: PHASE2
-
Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail
NCT01180647 ·Status: COMPLETED ·Phase: PHASE3
-
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence
NCT01549652 ·Status: COMPLETED ·Phase: NA
-
Biomarkers of Injectable Extended Release Naltrexone Treatment
NCT02324725 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Three Opioid Detoxification Treatment Regimens
NCT03678792 ·Status: WITHDRAWN ·Phase: PHASE3
-
Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone
NCT00637000 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1
NCT00142909 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain
NCT01358526 ·Status: COMPLETED ·Phase: PHASE3
-
Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence
NCT00332228 ·Status: COMPLETED ·Phase: PHASE2
-
Depot Naltrexone Treatment of Opioid Dependent Parolees
NCT00756990 ·Status: COMPLETED ·Phase: NA
-
Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone
NCT00577408 ·Status: COMPLETED ·Phase: PHASE3